Skip to main content
Margaret Tempero, MD, Oncology, San Francisco, CA, UCSF Medical Center

MargaretA.TemperoMD

Oncology • San Francisco, CA

Professor of Medicine, UCSF

Join to view full profile

Are you Dr. Tempero?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 53 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Margaret Tempero, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California, Iowa, and Nebraska. She is affiliated with UCSF Medical Center, Zuckerberg San Francisco General Hospital and Trauma Center, and San Francisco VA Medical Center.

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1982 - 1982
  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1977 - 1980
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2025
  • NE State Medical License
    NE State Medical License 1978 - 2016
  • IA State Medical License
    IA State Medical License 1985 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT Trial
    JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT TrialMay 15th, 2023
  • New Advisory Board Chair Has Been Part of PanCAN Since the Beginning
    New Advisory Board Chair Has Been Part of PanCAN Since the BeginningJuly 7th, 2021
  • The Pancreatic Cancer Action Network (PanCAN) Welcomes Two New Board Members and Scientific and Medical Advisory Board Chair
    The Pancreatic Cancer Action Network (PanCAN) Welcomes Two New Board Members and Scientific and Medical Advisory Board ChairJuly 6th, 2021
  • Join now to see all

Grant Support

  • Clinical Research Support ServicesNational Cancer Institute2007–2011
  • Mechanism-Based Evaluations Of Erbb-Targeted AgentsNational Cancer Institute2002–2006
  • Optimizing Radioimmunotherapy For Pancreatic CancerNational Cancer Institute1997–2002
  • Mechanism Based Evaluations Of ERBB Targeted AgentsNational Cancer Institute2001
  • Spore In Gastointestinal CancerNational Cancer Institute1997–1999
  • Unmc/Eppley Cancer Center Support GrantNational Cancer Institute1997–1998
  • Defining Toxicity And Benefit For RadioimmunotherapyNational Cancer Institute1993–1995

Professional Memberships

Hospital Affiliations

Dr. Margaret Tempero, Dr. Margaret Tempero, MD, Dr. M Tempero, Dr. Margaret A. Tempero